Livmed Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.40 M
- Revenue Growth 15.64%
- Profit Growth 100.05%
- Ebitda -110.94%
- Net Worth 21.46%
- Total Assets 10.51%
About Livmed Pharmaceutical
Livmed Pharmaceutical Private Limited (LPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 October 2020 (Four years and three months 14 days old ). Its registered office is in Cuttack, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.40 M.
Gorekha Sahoo and Himanshu Behera serve as directors at the Company.
Company Details
-
Location
Cuttack, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239OR2020PTC034502
-
Company No.
034502
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Oct 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Livmed Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gorekha Sahoo
|
Director | 19-Oct-2020 | Current |
|
Himanshu Behera
|
Director | 19-Oct-2020 | Current |
Financial Performance of Livmed Pharmaceutical.
Livmed Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.64% increase. The company also saw a substantial improvement in profitability, with a 100.05% increase in profit. The company's net worth Soared by an impressive increase of 21.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Livmed Pharmaceutical?
Unlock access to Livmed Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.40 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2022 | Canara Bank | ₹0.40 M | Open |
How Many Employees Work at Livmed Pharmaceutical?
Livmed Pharmaceutical has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Livmed Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Livmed Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.